Novo Nordisk was just served a punch to the stomach on its home turf in Denmark and has lost a major legal in-fight against its arch rival Sanofi, after the Danish Maritime and Commercial High Court judged in favor of Sanofi on every count, more or less.
This means the Danish pharmaceutical giant has to make an extensive rectification and needs to pay a major fine.
Get full access for you and your coworkers.Start a free company trial today
Already a member? Log in.